Stock IFRX INFLARX N.V.
Add to a list
To use this feature you must be a member
Log inSign up

News InflaRx N.V.

Equities

IFRX

NL0012661870

Delayed Nasdaq
Other stock markets
 12:59:58 2024-07-03 pm EDT 		5-day change 1st Jan Change
1.63 USD -5.78% Intraday chart for InflaRx N.V. +1.88% 0.00%
Jun. 24 Sector Update: Health Care Stocks Advance Monday Afternoon MT
Jun. 24 Sector Update: Health Care MT

Summary

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
InflaRx N : SALES AGREEMENT Form 6 K
PU
Sector Update: Health Care Stocks Advance Monday Afternoon
MT
Sector Update: Health Care
MT
InflaRx Anti-Inflammatory Drug Chosen for Phase 2 Acute Respiratory Distress Syndrome Trial; Shares Rise
MT
InflaRx’s GOHIBIC (Vilobelimab) Selected for First BARDA-Sponsored Clinical Trial to Evaluate Novel Host-Directed Therapeutics for Acute Respiratory Distress Syndrome (ARDS)
AQ
Inflarx?S Gohibic (Vilobelimab) Selected for First Barda-Sponsored Clinical Trial to Evaluate Novel Host-Directed Therapeutics for Acute Respiratory Distress Syndrome
CI
InflaRx Hosts R&D Event Highlighting the Promise of INF904
AQ
Transcript : InflaRx N.V. - Special Call
InflaRx N.V. Hosts R&D Event Highlighting the Promise of INF904
CI
InflaRx N : INF904 R&D Event
PU
InflaRx Presents New Analysis of PANAMO Phase III Trial in Severe COVID-19 at ATS 2024 Showing Potential Synergy With Vilobelimab When Used in Combination with Other Immunomodulators
AQ
InflaRx N.V. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
InflaRx Reports First Quarter 2024 Financial Results and Provides Business Update
AQ
InflaRx to Host Virtual R&D Event on June 5, 2024 and Report First Quarter 2024 Results on May 8, 2024
AQ
InflaRx N : 20240425_Minutes 2024 AGM - InflaRx NV_signed
PU
InflaRx N : Deed of Amendment to the Articles of Association, dated April 25, 2024 - Form 6-K
PU
InflaRx to Participate in Capital One Securities 1st Annual Biotech/Biopharma Disrupters Event
AQ
Transcript : InflaRx N.V. - Special Call
InflaRx N.V. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
InflaRx N : News Conference Call March 2024
PU
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. IFRX Stock
  4. News InflaRx N.V.